Birchview Capital LP Upped Oxford Immunotec Global Plc (OXFD) Holding; Schmidt P J Investment Management Raised Medtronic Plc (MDT) Stake

April 21, 2018 - By Michael Collier

Medtronic plc (NYSE:MDT) Logo

Birchview Capital Lp increased its stake in Oxford Immunotec Global Plc (OXFD) by 64.68% based on its latest 2017Q4 regulatory filing with the SEC. Birchview Capital Lp bought 50,000 shares as the company’s stock declined 10.21% with the market. The institutional investor held 127,303 shares of the in vitro & in vivo diagnostic substances company at the end of 2017Q4, valued at $1.78M, up from 77,303 at the end of the previous reported quarter. Birchview Capital Lp who had been investing in Oxford Immunotec Global Plc for a number of months, seems to be bullish on the $324.18 million market cap company. The stock decreased 3.17% or $0.41 during the last trading session, reaching $12.53. About 49,789 shares traded. Oxford Immunotec Global PLC (NASDAQ:OXFD) has declined 19.42% since April 21, 2017 and is downtrending. It has underperformed by 30.97% the S&P500.

Schmidt P J Investment Management Inc increased its stake in Medtronic Plc (MDT) by 16.9% based on its latest 2017Q4 regulatory filing with the SEC. Schmidt P J Investment Management Inc bought 3,791 shares as the company’s stock declined 4.15% with the market. The institutional investor held 26,217 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q4, valued at $2.12M, up from 22,426 at the end of the previous reported quarter. Schmidt P J Investment Management Inc who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $108.29B market cap company. The stock decreased 0.12% or $0.1 during the last trading session, reaching $79.9. About 3.69M shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since April 21, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Birchview Capital Lp, which manages about $161.00 million and $170.60 million US Long portfolio, decreased its stake in Celgene Corp (NASDAQ:CELG) by 17,000 shares to 744,051 shares, valued at $77.65M in 2017Q4, according to the filing.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $36,038 activity.

Among 4 analysts covering Oxford Immunotec (NASDAQ:OXFD), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Oxford Immunotec had 10 analyst reports since July 19, 2017 according to SRatingsIntel. Cowen & Co maintained it with “Buy” rating and $19.0 target in Wednesday, August 16 report. The firm earned “Buy” rating on Thursday, October 19 by Robert W. Baird. The rating was maintained by Cowen & Co with “Buy” on Wednesday, July 19. As per Tuesday, October 31, the company rating was maintained by Robert W. Baird. The rating was maintained by Cowen & Co on Monday, January 22 with “Buy”. On Wednesday, September 27 the stock rating was maintained by Cowen & Co with “Buy”. The rating was maintained by Cowen & Co on Tuesday, October 31 with “Buy”. Piper Jaffray maintained the shares of OXFD in report on Monday, January 8 with “Buy” rating. The stock of Oxford Immunotec Global PLC (NASDAQ:OXFD) has “Buy” rating given on Thursday, September 28 by BTIG Research.

Investors sentiment increased to 1.57 in 2017 Q4. Its up 0.44, from 1.13 in 2017Q3. It improved, as 11 investors sold OXFD shares while 17 reduced holdings. 13 funds opened positions while 31 raised stakes. 23.93 million shares or 6.29% more from 22.51 million shares in 2017Q3 were reported. 127,303 were accumulated by Birchview Ltd Partnership. Penn Capital has 212,868 shares for 0.21% of their portfolio. Redmile Gru Lc stated it has 2.32M shares or 1.41% of all its holdings. Moreover, Trexquant LP has 0.02% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 14,711 shares. Endurant Mgmt Lp holds 2.44% or 570,425 shares in its portfolio. Ny State Common Retirement Fund has invested 0% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD). California State Teachers Retirement Sys reported 39,908 shares or 0% of all its holdings. Price T Rowe Associate Md holds 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD) or 858,201 shares. Jefferies Lc invested in 19,511 shares or 0% of the stock. Geode Capital Ltd Limited Liability Company stated it has 64,839 shares. Morgan Stanley, a New York-based fund reported 60,373 shares. United Services Automobile Association accumulated 162,500 shares. Kennedy Cap Mngmt reported 98,912 shares. Wells Fargo Mn stated it has 0% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD). First Light Asset Mgmt Limited Co stated it has 2.29% in Oxford Immunotec Global PLC (NASDAQ:OXFD).

Schmidt P J Investment Management Inc, which manages about $434.11 million and $353.43M US Long portfolio, decreased its stake in Verizon Communications Inc (NYSE:VZ) by 8,555 shares to 124,208 shares, valued at $6.57 million in 2017Q4, according to the filing. It also reduced its holding in Boeing Co (NYSE:BA) by 2,007 shares in the quarter, leaving it with 9,067 shares, and cut its stake in Abbvie Inc (NYSE:ABBV).

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.10, from 1.12 in 2017Q3. It turned negative, as 65 investors sold MDT shares while 427 reduced holdings. 111 funds opened positions while 393 raised stakes. 1.04 billion shares or 2.98% less from 1.07 billion shares in 2017Q3 were reported. 900 are owned by Arcadia Management Mi. Beese Fulmer Inv Inc holds 0.99% or 57,241 shares. Lakeview Capital Prns Ltd Liability Com reported 2,830 shares. California-based Franklin Res has invested 1.47% in Medtronic plc (NYSE:MDT). Pittenger & Anderson owns 27,162 shares for 0.19% of their portfolio. Cheviot Value Management Ltd Limited Liability Company, California-based fund reported 65,249 shares. Swiss Savings Bank reported 0.49% of its portfolio in Medtronic plc (NYSE:MDT). First Natl stated it has 0.35% in Medtronic plc (NYSE:MDT). Orleans Capital La holds 1.76% or 30,563 shares in its portfolio. Texas-based Usca Ria Ltd Co has invested 0.35% in Medtronic plc (NYSE:MDT). Folger Nolan Fleming Douglas Management stated it has 0.05% in Medtronic plc (NYSE:MDT). Levin Capital Strategies LP has invested 0.04% of its portfolio in Medtronic plc (NYSE:MDT). Prudential Financial owns 3.36 million shares. Sumitomo Mitsui Asset Management Commerce holds 343,769 shares. Commerzbank Aktiengesellschaft Fi reported 338,320 shares.

Oxford Immunotec Global PLC (NASDAQ:OXFD) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>